Sangamo Therapeutics
SGMO
#10544
Rank
A$43.43 M
Marketcap
A$0.10
Share price
0.00%
Change (1 day)
-84.47%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -A$0.17 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$34.55 Million. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.17 Billion7.41%
2025 -A$0.16 Billion9.71%
2024 -A$0.14 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.26 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.11 Billion36.89%
2017 -A$79.86 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$66.39 Million75.62%
2014 -A$37.81 Million0.13%
2013 -A$37.76 Million
2011 -A$50.76 Million43.66%
2010 -A$35.33 Million28.52%
2009 -A$27.49 Million-23.55%
2008 -A$35.96 Million2.45%
2007 -A$35.1 Million19.5%
2006 -A$29.37 Million50.78%
2005 -A$19.48 Million75%
2004 -A$11.14 Million-33.25%
2003 -A$16.68 Million-62.27%
2002 -A$44.2 Million102.82%
2001 -A$21.8 Million23.21%
2000 -A$17.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.80 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.87 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.29 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.59 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$15.19 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.63 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.23 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA